Sus Clinicals is a biotechnology company that solves problems in qualifying new cancer drugs, devices, diagnostics, and therapies.
Sus Clinicals has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Sus Clinicals is headquartered in Cincinnati, United States.
Sus Clinicals is a biotechnology company that solves problems in qualifying new cancer drugs, devices, diagnostics, and therapies.
Sus Clinicals is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sus Clinicals — Funding & Investors." VCBacked, January 10, 2024, https://www.vcbacked.co/company/sus-clinicals. Accessed September 30, 2026.
VCBacked. (2024). Sus Clinicals — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/sus-clinicals
{{cite web |title=Sus Clinicals — Funding & Investors |url=https://www.vcbacked.co/company/sus-clinicals |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated